On October 22, 2006, the flags of Guangdong Kangzhi Pharmaceutical Co., Ltd. located in the urban area of ​​Guangdong Enping City fluttered and filled with a festive atmosphere. Leaders at all levels and colleagues in the pharmaceutical industry gathered at Enping and warmly celebrated the success of Guangdong Kangzhi Pharmaceutical Co., Ltd. in passing GMP certification and production. At the same time, they put the first batch of qualified products on the market.
The predecessor of Guangdong Kangzhi Pharmaceutical Co., Ltd. was Guangdong Changyi Pharmaceutical Co., Ltd., which was acquired by Kangzhi Group at the end of 2005. The factory covers an area of ​​45,000 square meters, a building area of ​​40,000 square meters and a green area of ​​about 25,000 square meters. The factory has advanced equipment and complete equipments. It has modern production lines such as capsules, tablets, granules, powders, and cephalosporin powder injections. It has 58 product approvals and huge development potential. After more than six months of GMP reform, in early August of this year, the powder injection and solid preparation workshops respectively passed the national GMP certification and were successfully put into operation.
The celebration party was grandly held at the Jinghu Hotel in Enping City. Mr. Hong Jiangyou, president of Kangzhi Group, put forward ardent expectations and a clear strategic plan for the development of Kangzhi Pharmaceutical. During the cocktail reception, a donation ceremony was also held by Guangdong Kangzhi Pharmaceutical Co., Ltd. to the Enping City Charity Association. Mr. Hong Jiangyou contributed 30,000 yuan to the Enping City Charity Association on behalf of the Kangzhi Group. He expressed that the leaders and employees of the Kangzhi Group are charitable for China. Strong support and sincere wishes for the cause.
Kangzhi Group is a private enterprise with 6 companies and annual revenue of over RMB 300 million, which integrates R&D, production and marketing. At the end of last year, investing in Enping, the acquisition of Yuanchangyi Pharmaceutical Factory was part of the group's strategic blueprint. With the strong support of the local government and leaders, the acquisition work was very smooth. The Group also immediately injected capital to carry out GMP renovation. So far, it has invested 35 million yuan. In May and August of this year, five production lines for powder injections and solid preparations passed the national GMP certification. Next year, the Group will increase investment, plan to put on two new production lines, strictly control the quality and implement the business philosophy of “Innovation of science and technology, quality first†to provide people with safe, effective and affordable medicines. To make a strong contribution to the economic construction of Enping City. At the same time, increase the research and development of new products in order to enhance the competitiveness of Guangdong Kangzhi Pharmaceutical Co., Ltd. and create more of their own famous brand products as soon as possible.
The predecessor of Guangdong Kangzhi Pharmaceutical Co., Ltd. was Guangdong Changyi Pharmaceutical Co., Ltd., which was acquired by Kangzhi Group at the end of 2005. The factory covers an area of ​​45,000 square meters, a building area of ​​40,000 square meters and a green area of ​​about 25,000 square meters. The factory has advanced equipment and complete equipments. It has modern production lines such as capsules, tablets, granules, powders, and cephalosporin powder injections. It has 58 product approvals and huge development potential. After more than six months of GMP reform, in early August of this year, the powder injection and solid preparation workshops respectively passed the national GMP certification and were successfully put into operation.
The celebration party was grandly held at the Jinghu Hotel in Enping City. Mr. Hong Jiangyou, president of Kangzhi Group, put forward ardent expectations and a clear strategic plan for the development of Kangzhi Pharmaceutical. During the cocktail reception, a donation ceremony was also held by Guangdong Kangzhi Pharmaceutical Co., Ltd. to the Enping City Charity Association. Mr. Hong Jiangyou contributed 30,000 yuan to the Enping City Charity Association on behalf of the Kangzhi Group. He expressed that the leaders and employees of the Kangzhi Group are charitable for China. Strong support and sincere wishes for the cause.
Kangzhi Group is a private enterprise with 6 companies and annual revenue of over RMB 300 million, which integrates R&D, production and marketing. At the end of last year, investing in Enping, the acquisition of Yuanchangyi Pharmaceutical Factory was part of the group's strategic blueprint. With the strong support of the local government and leaders, the acquisition work was very smooth. The Group also immediately injected capital to carry out GMP renovation. So far, it has invested 35 million yuan. In May and August of this year, five production lines for powder injections and solid preparations passed the national GMP certification. Next year, the Group will increase investment, plan to put on two new production lines, strictly control the quality and implement the business philosophy of “Innovation of science and technology, quality first†to provide people with safe, effective and affordable medicines. To make a strong contribution to the economic construction of Enping City. At the same time, increase the research and development of new products in order to enhance the competitiveness of Guangdong Kangzhi Pharmaceutical Co., Ltd. and create more of their own famous brand products as soon as possible.
Wuxi Yacai Precision Machinery Co., Ltd , https://www.yacaijm.com